– the leading provider of online annual reports to individual and institutional investors.

Intercell USA

Intercell USA discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free patch technology. The vaccine patch aims at enhancing the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The currently leading product candidates in development are a patch to prevent Travelers' Diarrhea and Pandemic Flu immunostimulant patch.

View Online Reports: Order Free Hardcopy You can request a free hardcopy of this report mailed to you by clicking the button below.
Add Annual Report

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports